Ribonucleic Acid News and Research

RSS
Link between COVID-19 severity and microbiome of saliva and nasopharynx

Link between COVID-19 severity and microbiome of saliva and nasopharynx

6 Jun 2022
Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

6 Jun 2022
CRISPR-based diagnostics for SARS-CoV-2 detection

CRISPR-based diagnostics for SARS-CoV-2 detection

6 Jun 2022
Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

6 Jun 2022
Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

3 Jun 2022
Brain motor and fear circuits orchestrate the immune response to acute stress

Brain motor and fear circuits orchestrate the immune response to acute stress

2 Jun 2022
Two cases of MIS-C after laboratory-confirmed SARS-CoV-2 breakthrough infections in fully vaccinated adolescent patients

Two cases of MIS-C after laboratory-confirmed SARS-CoV-2 breakthrough infections in fully vaccinated adolescent patients

2 Jun 2022
The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

2 Jun 2022
SARS-CoV-2 variation within individual hosts holds largely untapped information that may enhance the resolution of transmission inferences

SARS-CoV-2 variation within individual hosts holds largely untapped information that may enhance the resolution of transmission inferences

1 Jun 2022
Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

1 Jun 2022
Infection rates and immunological responses to SARS-CoV-2 infection among migrant workers

Infection rates and immunological responses to SARS-CoV-2 infection among migrant workers

1 Jun 2022
Structural and biochemical traits of main protease-mediated SARS-CoV-2 polyprotein processing

Structural and biochemical traits of main protease-mediated SARS-CoV-2 polyprotein processing

1 Jun 2022
Study investigates an outbreak of SARS-CoV-2 among children and adults after attending an overnight summer camp

Study investigates an outbreak of SARS-CoV-2 among children and adults after attending an overnight summer camp

1 Jun 2022
Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

31 May 2022
Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

31 May 2022
The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

31 May 2022
The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

31 May 2022
Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

31 May 2022
The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

31 May 2022
SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

31 May 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback